| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.075 | 0.01 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.01 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |